This study further expands our previous observation demonstrating the usefulness of combination therapy of anti-TNF-alpha and Cyclosporine A in the treatment of rheumatoid arthritis and concurrent hepatitis C virus infection, as well its efficacy and safety in controlling HCV viremia and liver toxicity. Seven patients were included in the study; transaminase levels remained unchanged, HCV RNA serum levels decreased significantly and DAS 28 significantly improved after twelve month follow-up. No side effects were registered.
|Number of pages||4|
|Journal||International Journal of Immunopathology and Pharmacology|
|Publication status||Published - Apr 2009|
- Anti TNF- α
- Rheumatoid arthritis
ASJC Scopus subject areas
- Immunology and Allergy